Marco Palla

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Journal of translational medicine

Expert opinion on drug safety

The Journal of dermatological treatment

Journal for immunotherapy of cancer

Istituto Nazionale Tumori IRCCS Fondazione Pascale

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Nazionale Tumori IRCCS Fondazione Pascale Mar 1o 2009

Italy

Medico - Dermatologo :: Ematologia e Terapie Innovative

Publications

Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caracò, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab. Journal of translational medicine 21 (1) (2023)
Marco Palla, Luigi Scarpato, Rossella Di Trolio, Paolo Antonio Ascierto
Sonic hedgehog pathway for the treatment of inflammatory diseases: implications and opportunities for future research. Journal for immunotherapy of cancer 10 (6) (2022)
Luigi Scarpato, Lucia Festino, Vito Vanella, Gabriele Madonna, Massimo Mastroianni, Marco Palla, Paolo Antonio Ascierto
Dermatologic adverse events associated with targeted therapies for melanoma. Expert opinion on drug safety (2021)
Victor Desmond Mandel, Matelda Medri, Ausilia Maria Manganoni, Laura Pavoni, Francesco De Rosa, Simone Ribero, Flavia Foca, Daniele Andreis, Laura Mazzoni, Serena Magi, Francesca Farnetani, Marco Palla, Paola Ulivi, Ignazio Stanganelli
Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications. The Journal of dermatological treatment (2020)

Marco Palla.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Palla